Groningen, Netherlands, November 18, 2026 -- SciSure, a provider of integrated software solutions for life sciences research, laboratory operati...
Oscar Health stock fell despite a Q3 earnings beat and raised guidance while LifeStance and HCA extended breakouts on earnings and payment news.
Detailed price information for Hca Holdings Inc (HCA-N) from The Globe and Mail including charting and trades.
Investing.com -- The clearest longer-term beneficiaries of Democratic gains are clean energy, regulated power, and hospitals. The election changes policy risk more than earnings overnight.
HCA stock and Oscar lead hospital and insurance stocks as Democratic control of Congress lifts hopes for limiting Medicaid cuts and reviving ACA subsidies.
Hospital operator HCA Healthcare (NYSE:HCA) reported Q3 2026 results beating Wall Street’s revenue expectations, with sales up 3.6% year on year to $19.85 billion. The company expects the full year’s revenue to be around $78.25 billion, close to analysts’ estimates. Its GAAP profit of $7.27 per share was 7% above analysts’ consensus estimates.
Shares of HCA dropped 4% after the U.S. hospital operator signaled earnings would stay flat in 2027, citing headwinds including an uptick in uninsured patients. HCA and other hospitals have been seeing an increase in uninsured patient volume this year because of the [expiration of federal subsidies
HCA Healthcare Inc (HCA) reaffirmed 2026 guidance and expects to land in the upper half of its ranges, even as exchange enrollment declines and uninsured volumes pressure margins.
The jump in uninsured patient costs sliced $400 million from pre-tax earnings.
This is the newest page. Registered accounts read further back.